Extrahepatic cholangiocarcinoma (perihilar and distal)

What changed: Extrahepatic cholangiocarcinoma (perihilar and distal)

Cancer page →

Every dated change on the records linked to Extrahepatic cholangiocarcinoma (perihilar and distal), newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Trial result4Milestone7This record1

FollowWatch this cancer and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2026-09-17This recordExtrahepatic cholangiocarcinoma (perihilar and distal)
Facts on this page last checked
When this page itself was last checked or edited.

2024 · 1

2024MilestoneZanidatamab
Zanidatamab receives accelerated approval for HER2-positive biliary tract cancer
A milestone in how this cancer is treated.

2023 · 1

2023Trial resultKEYNOTE-966
KEYNOTE-966 reported
OS 12.

2022 · 2

2021 · 1

2021MilestoneFOLFOX (5-FU, leucovorin, oxaliplatin)
ABC-06: FOLFOX as second line
A milestone in how this cancer is treated.

2019 · 1

2019MilestoneBILCAP
BILCAP: adjuvant capecitabine after resection
A milestone in how this cancer is treated.

2017 · 1

2017Trial resultBILCAP
BILCAP reported
OS 51.

2010 · 2

1975 · 1

1975MilestoneExtrahepatic cholangiocarcinoma (perihilar and distal)
Bismuth and Corlette classify perihilar tumours by ductal extension
A milestone in how this cancer is treated.

1965 · 1

1965MilestoneExtrahepatic cholangiocarcinoma (perihilar and distal)
Klatskin describes adenocarcinoma at the hepatic duct bifurcation
A milestone in how this cancer is treated.